Clinical Research Directory

Inclusion Criteria: 1. Ages 18-75 years,with no restriction on gender; 2. History of chest radiotherapy; 3. Diagnosed with grade 2-3 radiation-induced lung injury according to CTCAE 4.0 classification criteria in "Diagnosis and Treatment of Radiation-induced Lung Injury"; 4. Inadequate response to conventional treatment for two weeks, with no relief or progressive worsening of symptoms; 5. Well-controlled tumor for ≥3 months; 6. No significant liver or kidney dysfunction: ALT, AST ≤ 3 times the upper limit of normal, serum Cr and BUN ≤ 2 times the upper limit of normal; 7. Expected survival ≥ 3 months; 8. Informed consent signed voluntarily by the patient; 9. Willing and able to receive treatment and follow-up as required by the protocol, and able to comply with basic treatment as directed by the physician. Exclusion Criteria: 1. Severe cardiac insufficiency (such as NYHA class III or IV), uncontrolled hypertension (systolic blood pressure ≥160mmHg or diastolic blood pressure ≥110mmHg); 2. Positive for hepatitis B, hepatitis C, human immunodeficiency virus (HIV), or syphilis; 3. ECOG score ≥2; 4. Currently participating in or participated in other clinical trials within 4 weeks; 5. History of allergies or known allergy to the study preparation; 6. Patients with psychiatric disorders who cannot cooperate with treatment; (7) Pregnant or lactating women.